| PHASE I ENZYMES | Metabolic route | Model substrates | Drugs metabolized by route | Sex-specific activity |
| CYP1A | Caffeine, nicotine paracetamol (acetaminophen) | Clomipramine, clozapine, olanzapine, paracetamol, tacrine, theophylline | M > F [65] | CYP2C9 | Dapsone, (S)-mephenytoin | Ibuprofen, (S)-warfarin, tolbutamide, fluvastatin, glipizide, losartan, irbesartan, piroxicam, tolbutamide, phenytoin, fluvastatin, nelfinavir | M = F [66] | CYP2C19 | (S)-Mephenytoin Diazepam | Lansoprazole, omeprazole, hexobarbital, mephobarbital, citalopram, celecoxib, irbesartan, imipramine, piroxicam, propranolol (in part) | M = F [67] | CYP2D6 | Dextromethorphan, debrisoquine, sparteine | Codeine, encainide, flecainide, fluoxetine, hydrocodone, metoprolol, paroxetine, mexilitine, phenformin, propranolol, sertraline, timolol, haloperidol, clomipramine, desipramine, imipramine, propafenone, testosterone | M < F [68] | CYP2E1 | Chlorzoxazone | ā | M > F [69] | CYP3A | Midazolam, dapsone, cortisol, Lidocaine, nifedipine, erythromycin | Alprazolam, alfentanil, astemizole, atorvastatin, carbamazepine, cisapride, clarithromycin, cyclosporin, cyclophosphamide, diazepam,diltiazem, erythromycin, estradiol, fentanyl, indinavir, itraconazole, ketoconazole, lovastatin, quinidine, nimodipine, nisoldipine, quinidine, ritonavir, verapamil, tacrolimus, simvastatin, vincristine, vinblastine, tamoxifen, tirilazad, troglitazone | F > M [70] |
| PHASE II ENZYMES | Metabolic route | Model substrates | Drugs metabolized by route | Sex-specific activity |
| UDP-glucuronosyl-transferases | Caffeine | Clofibric acid, diflusinal, ibuprofen, mycophenolate, mofetil, paracetamol, zidovudine | M = F [68, 71] | Sulfotransferases | Caffeine | ā | M > F [72] | N-Acetyl-transferases | Caffeine, dapsone | Catecholamine derivatives, mercaptopurine, isoniazid, hydralazine | M = F [73] | Methyl-transferases | Norepinehrine, epinephrine | Azathioprine, dopamine, levodopa, 6-mercaptopurine, thioguanine, tazathioprine | M > F [74] |
|
|